<VariationArchive VariationID="11668" VariationName="NM_004586.3(RPS6KA3):c.1444_1959dup (p.Val482_Lys653dup)" VariationType="Duplication" Accession="VCV000011668" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-11" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26707" VariationID="11668">
      <GeneList>
        <Gene Symbol="RPS6KA3" FullName="ribosomal protein S6 kinase A3" GeneID="6197" HGNC_ID="HGNC:10432" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>Xp22.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="20149911" stop="20267097" display_start="20149911" display_stop="20267097" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="20168028" stop="20284749" display_start="20168028" display_stop="20284749" Strand="-" />
          </Location>
          <OMIM>300075</OMIM>
          <Haploinsufficiency last_evaluated="2022-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS6KA3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS6KA3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004586.3(RPS6KA3):c.1444_1959dup (p.Val482_Lys653dup)</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.2-p22.1</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>DUP EXONS 17-20, NT1959</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004586.3" sequenceAccession="NM_004586" sequenceVersion="3" change="c.1444_1959dup" MANESelect="true">
            <Expression>NM_004586.3:c.1444_1959dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007488.1" sequenceAccession="NG_007488" sequenceVersion="1" change="g.103742_114797dup">
            <Expression>NG_007488.1:g.103742_114797dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300075.0019" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="LocationOnGenomeAndProductNotAligned">The genomic duplication resulted in a direct tandem duplication of mRNA spanning exactly exons 17â€“20.</Comment>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided HGVS expressions for the genomic and product duplications from the sequences in the paper and supplementary material by Martinez-Garay et al., 2003 (PubMed 14986828).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004586.3(RPS6KA3):c.1444_1959dup (p.Val482_Lys653dup) AND Coffin-Lowry syndrome" Accession="RCV000012434" Version="15">
        <ClassifiedConditionList TraitSetID="3180">
          <ClassifiedCondition DB="MedGen" ID="C0265252">Coffin-Lowry syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2007-12-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17717706</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3180" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="823" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">COFFIN-LOWRY SYNDROME, MILD</ElementValue>
                <XRef Type="Allelic variant" ID="300075.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation with osteocartilaginous abnormalities</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Coffin syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Coffin-Lowry syndrome</ElementValue>
                <XRef ID="Coffin-Lowry+Syndrome/1709" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010561" DB="MONDO" />
                <XRef ID="15182000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CLS</ElementValue>
                <XRef Type="MIM" ID="303600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6123" />
                <XRef ID="6123" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Coffin-Lowry syndrome (CLS) is usually characterized by severe-to-profound intellectual disability in males; less severely impaired individuals have been reported. Neuropsychiatric concerns can include behavioral problems, loss of strength, progressive spasticity or paraplegia, sleep apnea, or stroke. Stimulus-induced drop attacks (SIDAs) in which unexpected tactile or auditory stimuli or excitement triggers a brief collapse but no loss of consciousness are present in approximately 20% of affected individuals. Typically SIDAs begin between mid-childhood and the teens. Characteristic facial features may be more apparent with age. Upper-extremity differences may be subtle and include short, soft, fleshy hands with tapered fingers as well as fleshy forearms. Progressive kyphoscoliosis is one of the most difficult aspects of long-term care. Affected females tend to have intellectual disability in the mild-to-moderate range and may also have the typical facial, hand, and skeletal findings noted in males.</Attribute>
                <XRef ID="NBK1346" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301520</ID>
                <ID Source="BookShelf">NBK1346</ID>
              </Citation>
              <XRef ID="192" DB="Orphanet" />
              <XRef ID="C0265252" DB="MedGen" />
              <XRef ID="MONDO:0010561" DB="MONDO" />
              <XRef Type="MIM" ID="303600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32668" SubmissionDate="2013-05-15" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300075.0019_COFFIN-LOWRY SYNDROME" title="RPS6KA3, DUP EXONS 17-20, NT1959_COFFIN-LOWRY SYNDROME" />
        <ClinVarAccession Accession="SCV000032668" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an 1.5-year-old boy with Coffin-Lowry syndrome (303600), Marques Pereira et al. (2007) identified an in-frame tandem duplication of exons 17 to 20, resulting from insertion of 516 nucleotides at nucleotide 1959, that arose from a homologous unequal recombination between Alu sequences. In vitro kinase assay showed that mutant RSK2 was inactive. The patient's mother, who had childhood scoliosis and difficulties in school, was found to carry the mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">17717706</ID>
              </Citation>
              <XRef DB="OMIM" ID="303600" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPS6KA3" />
          </GeneList>
          <Name>RPS6KA3, DUP EXONS 17-20, NT1959</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">DUP EXONS 17-20, NT1959</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300075.0019" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">COFFIN-LOWRY SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32668" TraitType="Disease" MappingType="Name" MappingValue="COFFIN-LOWRY SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0265252" Name="Coffin-Lowry syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

